Central Venous Catheter is a catheter inserted in to the large vein in the neck, chest, or groin when a patient needs cardiovascular monitoring, for analyzing of fluid status, and intravenous drugs and fluids can be given to the patient more easily, measure central venous pressure. The veins generally used are the internal jugular vein (neck), the subclavian vein (chest), and the femoral vein (groin).
Patients who are suffering with diseases such as cancer, cardiovascular diseases, and renal failure are unable to receive fluids or medication via the traditional route, meaning that they must be administered externally. This is done using a central venous catheter, which is placed on the central line.
Central Venous Catheter Market: Drivers & Restraints
Increasing more number of global patients in cardiovascular diseases, renal failure, cancer patients, and gastrointestinal (GI) infections leading to growth of central venous catheters market.
Catheter related bloodstream infection remains the most serious complication of central venous access and Bleeding disorders and expensive to treat.
Central Venous Catheter Market: Segmentation
Central Venous Catheter are broadly classified on the basis of product type, application and end user.
Browse Full Report@ http://www.futuremarketinsights.com/reports/central-venous-catheter-market
Based on the product type, central venous catheter segmented in to,
- Peripherally inserted central catheters (PICC)
- Tunneled Central Venous Catheter
- Non-Tunneled Central Venous Catheter
Based on the application, central venous catheter segmented in to,
- Cardiovascular procedures
- Chemotherapy procedures
- Dialysis procedures
Central Venous Catheter Market: Overview
According to recent WHO reports, Cancers is the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases and 8.2 million cancer related deaths in 2012, the number of new cases is expected to rise by about 70% over the next 2 decades this will help in growth of the Global central venous catheter market.
Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-949
According to WHO reports, an estimated 17.5 million people died from cardiovascular diseases in 2012, representing 31% of all global deaths, which leads to Healthy growth rate of Global Central Venous Catheter Market. The market for central venous catheter is expected to grow at a significant growth in the forecast years.
Central Venous Catheter Market: Region-wise Outlook
Based on geographic regions, globally infusion pump devices market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa
In North America region, the U.S. market occupied majority of market share because of increasing more number of cancers and cardiovascular patients. Asia is the fastest emerging market for global central venous catheter because of it is home to large patient base.
WHO reports says that, more than 60% of world’s total new annual cancer cases occur in Africa, Asia and Central and South America. These regions account for 70% of the world’s cancer deaths so there is huge scope for the development of central venous catheter in these regions.
Request Report TOC@ http://www.futuremarketinsights.com/toc/rep-gb-949
Central Venous Catheter Market: Key Players
Some of the key market players in global central venous catheter market are Teleflex Incorporated, C. R. Bard Inc, B.Braun Melsungen AG, Edwards Life sciences Corporation, Becton Dickinson Company, Terumo Corporation, and Smiths Medical.